Exploration of artificial intelligence in pharmacovigilance
Regulatory, medical writing and pharmacovigilance Type not stated
Disclosed: Verified:
During 2024, Viatris continued exploring emerging technologies, including artificial intelligence, to potentially enhance product safety evaluation, communication and risk mitigation.
Source
Company Archive pending